Search Results 1411-1420 of 9286 for scad
Scott H. Kaufmann, M.D., Ph.D. · Internist · Oncologist · Chair, Molecular Pharmacology and Experimental Therapeutics, Minnesota.
The purpose of this study is to demonstrate non-inferior 12-month overall survival of patients with GlioblastomA (GBM) treated with dose escalated ...
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by ...
To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...
This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...
Research. Mayo Clinic researchers collaborate with other academic centers across the nation to study brain injuries and perform clinical trials to help ...
This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
Bradley F. Boeve, M.D.. Chair, Behavioral Neurology, Minnesota. Request an Appointment · Overview · News ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Benefactor support fuels Mayo Clinic’s groundbreaking research. Make a gift today to help us save lives.